| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 127 securities · passive | ||||||
|
Korsana Biosciences, Inc.
13G
KRSA · 23255M303
|
5.2% |
11/16/2026
Event 9/30/2026
|
||||
|
Blossomhill Therapeutics, Inc.
13G
BLSM · 095130100
|
7.8% |
11/16/2026
Event 9/30/2026
|
||||
|
Titan Machinery Inc.
13G
TITN · 88830R101
|
5.0% |
11/16/2026
Event 9/30/2026
|
||||
|
Napco Security Technologies, Inc.
13G
NSSC · 630402105
|
5.1% |
11/16/2026
Event 9/30/2026
|
||||
|
Anterix Inc.
13G
ATEX · 03676C100
|
5.3% |
11/16/2026
Event 9/30/2026
|
||||
|
Definium Therapeutics, Inc.
13G
DFTX · 24477V105
|
5.4% |
11/16/2026
Event 9/30/2026
|
||||
|
Central Garden & Pet Co
13G
CENT · 153527106
|
7.3% |
11/16/2026
Event 9/30/2026
|
||||
|
Newamsterdam Pharma N.V.
13G
NAMS · N62509109
|
7.5% |
11/16/2026
Event 9/30/2026
|
||||
|
Tenax Therapeutics, Inc.
13G/A
TENX · 88032L605
|
0% |
11/16/2026
Event 9/30/2026
|
||||
|
Protara Therapeutics, Inc.
13G/A
TARA · 74365U107
|
0% |
11/16/2026
Event 9/30/2026
|
||||
|
Longeveron Inc.
13G/A
LGVN · 54303L203
|
4.4% |
11/16/2026
Event 9/30/2026
|
||||
|
Ligand Pharmaceuticals Incorporated
13G/A
LGND · 53220K504
|
4.6% |
11/16/2026
Event 9/30/2026
|
||||
|
Assembly Biosciences, Inc.
13G/A
ASMB · 045396207
|
3.3% |
11/16/2026
Event 9/30/2026
|
||||
|
Collegium Pharmaceutical, Inc.
13G/A
COLL · 19459J104
|
0.2% |
11/16/2026
Event 9/30/2026
|
||||
|
Biohaven Ltd.
13G/A
BHVN · G1110E107
|
1.4% |
11/16/2026
Event 9/30/2026
|
||||
|
Yarrow Bioscience, Inc.
13G/A
YARW · 92941V407
|
3.0% |
11/16/2026
Event 9/30/2026
|
||||
|
Rentokil Initial PLC
13G/A
RKLIF · G7494G105
|
3.3% |
11/16/2026
Event 9/30/2026
|
||||
|
Revolution Medicines, Inc.
13G/A
RVMD · 76155X100
|
3.5% |
11/16/2026
Event 9/30/2026
|
||||
|
DraftKings Inc.
13G/A
DKNG · 26142V105
|
4.2% |
11/16/2026
Event 9/30/2026
|
||||
|
Lantheus Holdings, Inc.
13G/A
LNTH · 516544103
|
4.2% |
11/16/2026
Event 9/30/2026
|
||||
|
Contineum Therapeutics, Inc.
13G/A
CTNM · 21217B100
|
4.6% |
11/16/2026
Event 9/30/2026
|
||||
|
Mirum Pharamaceuticals, Inc.
13G/A
MIRM · 604749101
|
8.5% |
11/16/2026
Event 9/30/2026
|
||||
|
Monopar Therapeutics Inc.
13G/A
MNPR · 61023L207
|
16.7% |
11/16/2026
Event 9/30/2026
|
||||
|
Lexeo Therapeutics, Inc.
13G/A
LXEO · 52886X107
|
7.2% |
11/16/2026
Event 9/30/2026
|
||||
|
Revvity, Inc.
13G/A
RVTY · 714046109
|
6.6% |
11/16/2026
Event 9/30/2026
|
||||
|
Edgewise Therapeutics, Inc.
13G/A
EWTX · 28036F105
|
6.7% |
11/16/2026
Event 9/30/2026
|
||||
|
Olema Pharmaceuticals, Inc.
13G/A
OLMA · 68062P106
|
7.2% |
11/16/2026
Event 9/30/2026
|
||||
|
Glaukos Corp
13G/A
GKOS · 377322102
|
7.9% |
11/16/2026
Event 9/30/2026
|
||||
|
WEX, Inc.
13G/A
WEX · 96208T104
|
8.6% |
11/16/2026
Event 9/30/2026
|
||||
|
Surgery Partners, Inc.
13G/A
SGRY · 86881A100
|
4.9% |
11/6/2026
Event 10/30/2026
|
||||
|
Eyepoint, Inc.
13G
EYPT · 30233G209
|
10.9% |
9/8/2026
Event 8/31/2026
|
||||
|
Vogenx, Inc.
13G
VOGX · 92859A106
|
13.0% |
9/8/2026
Event 8/31/2026
|
||||
|
Teleflex Incorporated
13G/A
TFX · 879369106
|
10.3% |
9/8/2026
Event 8/31/2026
|
||||
| JANUS HENDERSON GROUP Ltd. | 10.3% | |||||
| Janus Henderson Enterprise Fund | 6.8% | |||||
|
Ziff Davis, Inc.
13G/A
ZD · 48123V102
|
10.3% |
9/8/2026
Event 8/31/2026
|
||||
|
Forte Biosciences, Inc.
13G/A
FBRX · 34962G208
|
9.3% |
8/13/2026
Event 6/30/2026
|
||||
|
Tarsus Pharmaceuticals, Inc.
13G/A
TARS · 87650L103
|
6.5% |
8/13/2026
Event 6/30/2026
|
||||
|
Dyne Therapeutics, Inc.
13G/A
DYN · 26818M108
|
7.3% |
8/13/2026
Event 6/30/2026
|
||||
|
ICU Medical, Inc.
13G/A
ICUI · 44930G107
|
11.1% |
8/13/2026
Event 6/30/2026
|
||||
|
Immix Biopharma, Inc.
13G/A
IMMX · 45258H106
|
14.0% |
8/13/2026
Event 6/30/2026
|
||||
|
Janux Therapeutics, Inc.
13G/A
JANX · 47103J105
|
0.3% |
8/13/2026
Event 6/30/2026
|
||||
|
Flex Ltd.
13G/A
FLEX · Y2573F102
|
3.8% |
8/13/2026
Event 6/30/2026
|
||||
|
Bicara Therapeutics Inc.
13G/A
BCAX · 055477103
|
4.8% |
8/13/2026
Event 6/30/2026
|
||||
|
Bel Fuse Inc.
13G/A
BELFB · 077347300
|
4.8% |
8/13/2026
Event 6/30/2026
|
||||
|
Ocugen, Inc.
13G/A
OCGN · 67577C105
|
3.0% |
8/13/2026
Event 6/30/2026
|
||||
|
Achieve Life Sciences, Inc.
13G
ACHV · 004468500
|
5.4% |
8/13/2026
Event 6/30/2026
|
||||
|
Inspired Entertainment, Inc.
13G
INSE · 45782N108
|
5.0% |
8/13/2026
Event 6/30/2026
|
||||
|
LPL Financial Holdings Inc.
13G
LPLA · 50212V100
|
5.3% |
8/13/2026
Event 6/30/2026
|
||||
|
OSI Systems, Inc.
13G
OSIS · 671044105
|
5.5% |
8/13/2026
Event 6/30/2026
|
||||
|
Jatt II Acquisition Corp.
13G
JATT · G50765109
|
6.2% |
8/13/2026
Event 6/30/2026
|
||||
|
Vaxcyte, Inc.
13G/A
PCVX · 92243G108
|
12.1% |
8/11/2026
Event 7/31/2026
|
||||
|
Privacore VPC Asset Backed Credit Fund
13G
74291E300
|
17.1% |
7/8/2026
Event 6/30/2026
|
||||
|
Privacore Pcaam Alternative Growth Fund
13G
74290Y307
|
46.8% |
7/8/2026
Event 6/30/2026
|
||||
|
Privacore Pcaam Alternative Income Fund
13G
74291A308
|
67.4% |
7/8/2026
Event 6/30/2026
|
||||
|
Jade Biosciences, Inc.
13G/A
JBIO · 008064206
|
10.6% |
7/8/2026
Event 6/30/2026
|
||||
|
Cellectar Biosciences, Inc.
13G
CLRB · 15117F880
|
10.0% |
6/5/2026
Event 5/29/2026
|
||||
|
Tyra Biosciences, Inc.
13G/A
TYRA · 90240B106
|
7.2% |
5/15/2026
Event 3/31/2026
|
||||
|
PTC Therapeutics, Inc.
13G/A
PTCT · 69366J200
|
8.7% |
5/15/2026
Event 3/31/2026
|
||||
|
Maze Therapeutics, Inc.
13G/A
MAZE · 578784100
|
5.8% |
5/15/2026
Event 3/31/2026
|
||||
|
Madrigal Pharmaceuticals, Inc.
13G/A
MDGL · 558868105
|
8.8% |
5/15/2026
Event 3/31/2026
|
||||
|
IDEAYA Biosciences, Inc.
13G/A
IDYA · 45166A102
|
8.3% |
5/15/2026
Event 3/31/2026
|
||||
|
Gildan Activewear Inc
13G/A
GIL · 375916103
|
5.7% |
5/15/2026
Event 3/31/2026
|
||||
|
Bright Minds Biosciences Inc.
13G/A
DRUG · 10919W405
|
13.1% |
5/15/2026
Event 3/31/2026
|
||||
|
BridgeBio Pharma, Inc.
13G/A
BBIO · 10806X102
|
6.8% |
5/15/2026
Event 3/31/2026
|
||||
|
Ascendis Pharma A/S
13G/A
ASND · 04351P101
|
6.0% |
5/15/2026
Event 3/31/2026
|
||||
|
Minerva Neurosciences, Inc
13G
NERV · 603380205
|
9.9% |
5/15/2026
Event 3/31/2026
|
||||
|
Stride, Inc.
13G
LRN · 86333M108
|
5.4% |
5/15/2026
Event 3/31/2026
|
||||
|
Dayforce, Inc.
13G/A
DAY · 15677J108
|
0% |
5/15/2026
Event 3/31/2026
|
||||
|
Ardelyx, Inc.
13G/A
ARDX · 039697107
|
3.4% |
5/15/2026
Event 3/31/2026
|
||||
|
Xenon Pharmaceuticals Inc.
13G/A
XENE · 98420N105
|
4.5% |
5/15/2026
Event 3/31/2026
|
||||
|
SS&C Technologies Holdings, Inc
13G/A
SSNC · 78467J100
|
3.5% |
5/15/2026
Event 3/31/2026
|
||||
|
Soleno Therapeutics, Inc.
13G/A
SLNO · 834203309
|
2.3% |
5/7/2026
Event 4/30/2026
|
||||
|
Adagene Inc.
13G
ADAG · 005329107
|
10.1% |
5/7/2026
Event 4/30/2026
|
||||
|
Promis Neurosciences Inc.
13G
PMN · 74346M505
|
14.4% |
4/7/2026
Event 3/31/2026
|
||||
|
4D Molecular Therapeutics, Inc.
13G/A
FDMT · 35104E100
|
10.3% |
4/7/2026
Event 3/31/2026
|
||||
|
Cimpress PLC
13G/A
CMPR · G2143T103
|
14.7% |
2/17/2026
Event 12/31/2025
|
||||
| Janus Henderson Group PLC | 14.7% | |||||
| Janus Henderson Enterprise Fund | 9.6% | |||||
|
VistaGen Therapeutics, Inc.
13G/A
VTGN · 92840H400
|
0% |
2/17/2026
Event 12/31/2025
|
||||
|
Sensient Technologies Corporation
13G/A
SXT · 81725T100
|
4.9% |
2/17/2026
Event 12/31/2025
|
||||
|
Metsera, Inc.
13G/A
MTSR · 59267L107
|
3.1% |
2/17/2026
Event 12/31/2025
|
||||
|
Mereo Biopharma Group PLC
13G/A
MREO · 589492107
|
0% |
2/17/2026
Event 12/31/2025
|
||||
|
Akero Therapeutics, Inc.
13G/A
AKRO · 00973Y108
|
4.1% |
2/17/2026
Event 12/31/2025
|
||||
|
Avadel Pharmaceuticals plc
13G/A
AVDL · G29687103
|
1.9% |
2/17/2026
Event 12/31/2025
|
||||
|
Avidity Biosciences, Inc.
13G/A
RNAM · 05370A108
|
4.6% |
2/17/2026
Event 12/31/2025
|
||||
|
Equillium, Inc.
13G/A
EQ · 29446K106
|
10.0% |
2/6/2026
Event 1/30/2026
|
||||
|
Relmada Therapeutics, Inc.
13G
RLMD · 75955J402
|
10.1% |
2/6/2026
Event 1/30/2026
|
||||
|
DBV Technologies S.A.
13G/A
DBV.PA · F2927N109
|
8.8% |
1/8/2026
Event 12/31/2025
|
||||
|
CAMP4 Therapeutics Corp
13G
CAMP · 13463J101
|
12.2% |
1/8/2026
Event 12/31/2025
|
||||
|
Pasithea Therapeutics Corp.
13G
KTTA · 70261F202
|
10.0% |
12/8/2025
Event 11/28/2025
|
||||
|
Palisade Bio, Inc.
13G
PALI · 696389402
|
10.0% |
12/8/2025
Event 11/28/2025
|
||||
| Janus Henderson Group PLC | 10.0% | |||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.0% | |||||
|
Palatin Technologies Inc
13G
PTN · 696077601
|
10.0% |
12/8/2025
Event 11/28/2025
|
||||
| Janus Henderson Group PLC | 10.0% | |||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.6% | |||||
|
Ovid Therapeutics Inc.
13G
OVID · 690469101
|
10.0% |
12/8/2025
Event 11/28/2025
|
||||
|
Inovio Pharmaceuticals, Inc.
13G/A
INO · 45773H409
|
10.0% |
12/8/2025
Event 11/28/2025
|
||||
|
Immunic, Inc.
13G
IMUX · 4525EP101
|
10.0% |
12/8/2025
Event 11/28/2025
|
||||
|
Biomea Fusion, Inc.
13G
BMEA · 09077A106
|
5.0% |
12/8/2025
Event 11/28/2025
|
||||
|
Benitec Biopharma Inc.
13G/A
BNTC · 08205P209
|
10.0% |
12/8/2025
Event 11/28/2025
|
||||
| Janus Henderson Group PLC | 10.0% | |||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.1% | |||||
|
Travere Therapeutics, Inc.
13G/A
TVTX · 89422G107
|
11.9% |
11/14/2025
Event 9/30/2025
|
||||
|
Asure Software Inc
13G/A
ASUR · 04649U102
|
6.1% |
11/14/2025
Event 9/30/2025
|
||||
| Janus Henderson Group PLC | 6.1% | |||||
| Janus Henderson Venture Fund | 5.7% | |||||
|
Sensata Technologies Holding PLC
13G/A
ST · G8060N102
|
6.9% |
11/14/2025
Event 9/30/2025
|
||||
|
Structure Therapeutics Inc.
13G/A
GPCR · 86366E106
|
7.7% |
11/14/2025
Event 9/30/2025
|
||||
|
Liberty Media Corporation
13G/A
FWONK · 531229755
|
4.8% |
11/14/2025
Event 9/30/2025
|
||||
|
Invivyd, Inc.
13G/A
IVVD · 00534A102
|
12.1% |
11/14/2025
Event 9/30/2025
|
||||
| Janus Henderson Group PLC | 12.1% | |||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.